The drive-through COVID-19 vaccination in Yogyakarta

https://doi.org/10.22146/jcoemph.82335

Lukman Ade Chandra(1*), Hera Nirwati(2), Ika Puspitasari(3), Ajib Dibtyanusa(4), Sutono Sutono(5), Bayu Fandi Achmad(6), Intan Fatah Kumara(7), Rukmono Siswishanto(8)

(1) Universitas Gadjah Mada
(2) 
(3) 
(4) 
(5) 
(6) 
(7) 
(8) 
(*) Corresponding Author

Abstract


Introduction: COVID-19 vaccination is the government's priority to control viral transmission. Drive-through system provides quick means of product or service delivery; however, it has not been extensively adopted as a vaccination method. This study aims to describe the implementation of the drive-through COVID-19 vaccination conducted by the Faculty of Medicine, Public Health, and Nursing at Universitas Gadjah Mada in collaboration with several national and regional, governmental and non-governmental institutions. Methods: The drive-through vaccination involved online registration, data collecting, reporting, on-site dose preparation, injection, and post-vaccination monitoring while participants remained in their vehicles. The events were scheduled between July and September 2021 in either FK-KMK UGM Campus or Grha Sabha Pramana, UGM. These venues are on the inner property side of UGM, therefore is no disruption of public traffic. Participants who are eligible and receive an invitation may attend the immunization venue according to the schedule. Results: In ten vaccination events, 20,870 doses of the COVID-19 vaccine were administered. Most participants were young people, with slightly more women than men. The drive-through vaccination went relatively well and offered many benefits such as improving vaccine coverage, time efficiency, social distancing, and herd immunity. Yet, issues like mild Adverse events following immunization and an accumulation of vehicles occurred. Therefore, careful planning and risk anticipation are necessary. Conclusion: The drive-through vaccination generally provides rapid and safe vaccine delivery to large communities. This method could be an alternative to delivering mass vaccinations requiring rapid and extensive coverage.


Keywords


COVID-19; drive-through; immunization; vaccination;

Full Text:

PDF


References

1 Kementerian Komunikasi dan Informasi. Situasi COVID-19 di Indonesia Jakarta: Kementerian Komunikasi dan Informasi; 2022 [Available from: https://covid19.go.id/artikel/2023/02/04/situasi-covid-19-di-indonesia-update-4-februari-2023.

2 Surendra H, Elyazar IR, Djaafara BA, Ekawati LL, Saraswati K, Adrian V, et al. Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study. The Lancet Regional Health-Western Pacific. 2021;9:100108.

3 Fadlyana E, Rusmil K, Tarigan R, Rahmadi AR, Prodjosoewojo S, Sofiatin Y, et al. A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: an interim analysis in Indonesia. Vaccine. 2021;39(44):6520-8.

4 Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England journal of medicine. 2020;383(27):2603-15.

5 Setditjen Farmalkes. Dukungan Penyediaan Vaksin bagi Keberhasilan Pelaksanaan Vaksinasi COVID-19. Kementerian Kesehatan. 2022 11 Januari 2022

6 Tamara T. Gambaran Vaksinasi COVID-19 di Indonesia pada Juli 2021. Medical Profession Journal of Lampung. 2021;11(1):180-3.

7 Kementerian Kesehatan Republik Indonesia. Rekap tempat tidur covid di rs Sumber data: pelaporan covid di rs 5 juli 2021. Jakarta: Kemenkes RI; 2021.

8 Komite Penangangan Pemulihan Ekonomi Nasional. Peta Sebaran COVID-19 2021.

9 Carrico RM, FSHEA C, McKinney WP, Nicholas Adam Watson J, Wiemken T, Myers J. Drive-thru influenza immunization: fifteen years of experience. Journal of Emergency Management. 2012;10(3):228-32.

10 Tim Komunikasi KPCPEN. Kemenkes Sediakan Layanan Drive Thru Vaksinasi COVID-19 Bagi Lansia panrb. 2021 05 Maret 2021

11 Asgary A, Najafabadi MM, Karsseboom R, Wu J, editors. A drive-through simulation tool for mass vaccination during COVID-19 pandemic. Healthcare; 2020: MDPI.

12 Weiss EA, Ngo J, Gilbert GH, Quinn JV. Drive-through medicine: a novel proposal for rapid evaluation of patients during an influenza pandemic. Annals of emergency medicine. 2010;55(3):268-73.

13 Garrison G. Here’s What a Birmingham Clinic CEO Learned from 2,200 COVID-19 Tests 2020 [Available from: https://www.al.com/coronavirus/2020/03/heres-what-a-birmingham-clinic-ceo-learned-from-2200-covid-19-tests.html

14 Lee D, Lee J. Testing on the move: South Korea's rapid response to the COVID-19 pandemic. Transportation Research Interdisciplinary Perspectives. 2020;5:100111.

15 Asgary A, Najafabadi MM, Wendel SK, Resnick-Ault D, Zane RD, Wu J. Optimizing planning and design of COVID-19 drive-through mass vaccination clinics by simulation. Health and Technology. 2021;11:1359-68.



DOI: https://doi.org/10.22146/jcoemph.82335

Article Metrics

Abstract views : 886 | views : 549

Refbacks

  • There are currently no refbacks.


Copyright (c) 2024 Journal of Community Empowerment for Health

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.